Aier Eye Hospital Group Receives Zeiss 'Dual Global Leadership Awards' and 'Surgical Quality Improvement Award'

Shanghai, May 25, 2018 /PRNewswire/ -- On May 25, Aier Eye Hospital Group Co., Ltd. (hereinafter referred to as "Aier Eye Hospital") was awarded the "Surgical Quality Control Improvement Award" (hereinafter referred to as the "Quality Improvement Award") and recognized for having "the highest number of installations at a single institution globally and the largest volume of femtosecond SMILE surgeries globally" by Carl Zeiss.”(hereinafter referred to as “SMILE Dual Best”)）Title. The award and plaque presentation ceremony was held at the Sheraton Shanghai Jiading Hotel. Mr. Li Li, President of Aier Eye Hospital, received the “SMILE Double Best” plaque from Professor Steve Schalhorn, Global Chief Medical Officer of Carl Zeiss. Dr. Wang Zheng, Dean of Aier Eye Hospital, accepted the “Quality Improvement Award” medal on behalf of the Refractive Surgery Group from Mr. Paolo Gianese, Global Manager of Carl Zeiss.

Aier Eye Hospital is a leading ophthalmic medical group in China and globally, with hospital scale and medical capabilities that rank among the top. Covering Asia, Europe, and North America, it operates more than 300 eye hospitals and centers, serving over 6 million outpatient visits annually. Over the years, Aier Eye Hospital has been committed to introducing and integrating internationally synchronized ophthalmic technologies and healthcare management concepts. Guided by a development strategy centered on specialization, large-scale operations, and scientific management, it has promoted the advancement of ophthalmic care in China. Leveraging its advantages in talent, technology, and management, and through excellent diagnostic and treatment quality, high-quality medical services, and effective doctor–patient communication across its nationwide chain of hospitals, Aier Eye Hospital has become a trusted provider for ophthalmic patients throughout China. As a close partner of Carl Zeiss, it has made positive contributions to advancing the development of ophthalmic healthcare in China.

In his address, Professor Steve Schalhorn, Global Chief Medical Officer of Carl Zeiss, congratulated Aier Eye Hospital on receiving two major honors simultaneously: “Aier Eye Hospital is a close partner of Carl Zeiss, boasting leading medical capabilities and growing global influence. Over the years, by leveraging continuous innovation—particularly its remarkable and highly respected quality control system—Aier Eye Hospital has facilitated the rapid and widespread adoption of advanced refractive treatment equipment and technologies such as SMILE (Small Incision Lenticule Extraction), benefiting millions of myopia patients. This has contributed significantly to eye health in China and set a benchmark for quality control in the field of refractive surgery correction. I would like to express my gratitude to Aier Eye Hospital, especially its refractive surgery team, for their efforts in driving transformation and progress in the refractive industry, and extend my heartfelt congratulations on their achievements.””

Mr. Li Li, President of Aier Eye Hospital, expressed his sincere gratitude for Carl Zeiss’s unwavering support: “We thank Carl Zeiss for its long-standing and robust support of Aier Eye Hospital. It is precisely through this specialized support and Carl Zeiss’s advanced technological equipment that Aier Eye Hospital has built a team of expert clinicians with extensive clinical experience and exceptional technical proficiency. Since the establishment of our refractive surgery program in 2002, we have consistently adhered to eight leading principles—standardization, examination, professionalism, service, safety, experience, technology, and scientific research—perfectly embodying our brand identity as ‘the authority in myopia care with international quality,’ thereby earning the trust and respect of 1.5 million patients.” Regarding the dual honors of being named the “Double Best in SMILE” and receiving the “Quality Improvement Award,” Mr. Li stated: “This represents significant recognition and encouragement for the work of Aier Eye Hospital’s refractive surgery department and our entire group. Taking this as a new starting point, we will further strengthen our collaboration with Carl Zeiss, leveraging its advanced equipment and technical support to continuously enhance the quality of refractive treatment and services. We remain committed to reinforcing our role as a model and leader within China, while continuing to elevate the stature of Chinese healthcare on the international stage.””

It is reported that the SMILE (Small Incision Lenticule Extraction) procedure, performed using femtosecond laser technology, is currently one of the most advanced modalities for corneal refractive laser surgery worldwide, marking a new milestone in the safety and precision of myopia correction surgeries. Professor Wang Zheng, academic leader of the Refractive Surgery Group at Aier Eye Hospital and Dean of Guangzhou Aier Eye Hospital, stated while accepting the “Quality Improvement Award”: “SMILE surgery represents the future trend in the development of refractive surgery. China is at the forefront internationally, both in terms of clinical surgical practice and academic research.”

As a revolutionary, epoch-making innovation in myopia correction, the SMILE (Small Incision Lenticule Extraction) procedure offers the clinical advantages of being flapless and minimally invasive. Characterized by painless intraoperative experience, high predictability, rapid postoperative visual recovery, and stable corneal biomechanics, it provides robust technical support for enhancing the safety and comfort of myopia surgery. Consequently, it has gained widespread trust among ophthalmologists worldwide and serves as a significant benefit for patients with myopia.